Shi-Yi Wang on Shifting End-of-Life Treatment Paradigms

Video

Shi-Yi Wang, MD, PhD, assistant professor of Epidemiology at Yale School of Public Health, discusses the need for change in aggressive end-of-life cancer treatment.

Shi-Yi Wang, MD, PhD, assistant professor of Epidemiology at Yale School of Public Health, discusses the need for change in aggressive end-of-life cancer treatment.

In a study that analyzed Medicare data, Wang found that early hospice enrollment can potentially decrease end-of-life expenditures, but only when the expenditures are higher to begin with. Wang says that aggressive end-of-life care is the current norm, so doctors typically follow suit, regardless of whether or not the care is warranted. He is hoping that this research will motivate leaders in the field to carefully consider the cost and effectiveness of hospice and end-of-life care and make decisions accordingly.

Related Videos
Meaghan Mooney, B.S.N., RN, OCN, during the Extraordinary Healer interview
Colleen O’Leary, DNP, RN, AOCNS, EBP-C, LSSYB, in an interview with Oncology Nursing News.
Michelle H. Johann, DNP, RN, PHN, CPAN, WTA, in an interview with Oncology Nursing News explaining surgical path cards
Alison Tray, of Hartford Healthcare, discusses her team's research on a multidisciplinary team approach to manage the cancer drug shortage
Related Content
© 2024 MJH Life Sciences

All rights reserved.